Regulatory News
Tuesday, November 22, 2016
BRIEF-TG Therapeutics announces positive DSMB recommendation
* TG Therapeutics announces positive DSMB recommendation for
continuation of the UNITY-CLL phase 3 trial
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment